Alcon Total Current Liabilities 2019-2025 | ALC

Alcon total current liabilities for the quarter ending March 31, 2025 were $2.246B, a 1.1% decline year-over-year.

  • Alcon total current liabilities for 2024 were $2.278B, a 5% decline from 2023.
  • Alcon total current liabilities for 2023 were $2.398B, a 12.42% decline from 2022.
  • Alcon total current liabilities for 2022 were $2.738B, a 10.76% increase from 2021.

Alcon Total Current Liabilities 2019-2025 | ALC

  • Alcon total current liabilities for 2024 were $2.278B, a 5% decline from 2023.
  • Alcon total current liabilities for 2023 were $2.398B, a 12.42% decline from 2022.
  • Alcon total current liabilities for 2022 were $2.738B, a 10.76% increase from 2021.
Related Stocks
Company NameMarket
Cap
Intuitive Surgical (ISRG)$179.9B
Thermo Fisher Scientific (TMO)$176.2B
Edwards Lifesciences (EW)$45.1B
IDEXX Laboratories (IDXX)$43.5B
DexCom (DXCM)$33.9B
IQVIA Holdings (IQV)$33B
Mettler-Toledo (MTD)$26.1B
STERIS (STE)$22.2B
SONOVA HOLDING (SONVY)$17.7B
Waters (WAT)$17.6B
Hologic (HOLX)$14.7B
Sysmex ADR (SSMXY)$10.8B
Penumbra (PEN)$9B
Masimo (MASI)$8.9B
Globus Medical (GMED)$7.3B
Glaukos (GKOS)$5.5B
Teleflex (TFX)$5.2B
Integer Holdings (ITGR)$4B
TransMedics (TMDX)$3.7B
PROCEPT BioRobotics (PRCT)$3.3B
LivaNova (LIVN)$2.4B
Nihon Kohden (NHNKY)$2.2B
Elekta AB (EKTAY)$2B
Veracyte (VCYT)$1.9B
Alphatec Holdings (ATEC)$1.6B
Artivion (AORT)$1.3B
OPKO Health (OPK)$1.1B
Paragon 28 (FNA)$1.1B
Tandem Diabetes Care (TNDM)$1.1B
Pulse Biosciences (PLSE)$1B